MyAverix Finance
US · Healthcare
Nykode Therapeutics AS (VACBF)
Biotechnology
Nykode Therapeutics AS (VACBF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VACBF
Nykode Therapeutics AS (VACBF) — FAQ
What is VACBF's P/E ratio?
The price-to-earnings (P/E) ratio for Nykode Therapeutics AS (VACBF) is 18.00 (data as of 2026-03-25).
Does Nykode Therapeutics AS pay a dividend?
Dividend yield is not available in the current snapshot for Nykode Therapeutics AS (VACBF). Check the MyAverix Finance app for the latest dividend data.
What sector is Nykode Therapeutics AS in?
Nykode Therapeutics AS (VACBF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is VACBF listed on?
VACBF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.